Enhance your practice with CMEand tools that focus on the managementand treatment of patients with cancer.
Contrasting TROP2-Targeted ADCs in Breast Cancer Therapy
Kevin Kalinsky MD, MS
Komal Jhaveri, MD, FACP
Assessing Efficacy and Cost of Blood-Based Tests for Colorectal Cancer
Charles Turck, PharmD, BCPS, BCCCP
Samuel Muench, MD
Biomarker Breakthroughs: A Look at What’s Next for Kidney Cancer Care
Ryan Quigley
David F. McDermott, MD
Uncovering Unmet Needs in Squamous Cell Carcinoma of the Anal Canal Care
Richard Kim, MD
Subcutaneous Cancer Immunotherapy at Home: Transforming Trials and Patient Care
Jorge Nieva, MD
New Frontiers in the Imaging and Treatment of Advanced Prostate Cancer
Wayne Kuang, MD
William Oh, MD
Bringing Cancer Care Home: How Subcutaneous Immunotherapy Can Help Ease the Burden
Why Words Matter: Rethinking Terminology in Advanced Prostate Cancer
First-line Chemotherapy Options in Metastatic PDAC
Eileen O’Reilly, MD
Chemotherapy Strategies in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Efrat Dotan, MD
Mastering Mutation-Driven mCRC: From Testing to Targeted Therapy
Jenny Seligmann, MBChB, PhD
Fortunato Ciardiello, MD, PhD
Scott Kopetz, MD, PhD
Cathy Eng, MD, FACP
Mutational Testing in mCRC: Methods and Data Driving Treatment Selection
DLL3 Expression in GEP-NECs: A Marker of Poor Differentiation and Emerging Therapeutic Target
Liquid Biopsy for Colorectal Cancer Screening: Benefits and Barriers
Brennan Spiegel, MD, MSHS
Studying Carboplatin-Paclitaxel + Retifanlimab for Squamous Cell Carcinoma of the Anal Canal
Early-Onset Endometrial Cancer: Bridging the Gap Between Age and Outcome
Optimizing Nivolumab in NSCLC: Implications for Cost, Access, and Outcomes
Aline Fares, MD
One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
Unpacking the Logistics of At-Home Subcutaneous Cancer Immunotherapy Delivery
Investigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.